...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia

Results from these analyses will pave the way for a planned dementia-focused clinical trial.

There is no IF in the previous sentence. Almost sounds like a given we will have a dementia trial!

Share
New Message
Please login to post a reply